2027 ICD-10-CM Diagnosis Code G31.89Other specified degenerative diseases of nervous system
ICD-10-CM Codes›G00–G99›G30-G32›G31
- Billable — Valid for Submission
- Chronic Condition
G31.89 is a billable ICD-10-CM diagnosis code for other specified degenerative diseases of nervous system. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 56 through 57. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other nervous system disorders (often hereditary or degenerative).
G31.89 no longer risk-adjusts for Medicare Advantage: it mapped to HCC 52 under the retired CMS-HCC V24 model through payment year 2025 but maps to no category in the live V28 model. It still risk-adjusts in the ESRD (V21) category 52, ESRD (V24) category 52, and RxHCC Part D (V08) category 112 for payment year 2027.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
G31.89 no longer risk-adjusts for Medicare Advantage: it maps to no payment category in the live CMS-HCC V28 model, although it still risk-adjusts in the other CMS models shown below.
Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- 3-Methylglutaconic aciduria type 4
- Acquired cerebellar atrophy
- Acute cerebellar syndrome
- Argyrophilic grain disease
- Arteriopathic granular atrophy of cerebral cortex
- Atrophy of cerebellar vermis
- Atrophy of corticospinal tract
- Atrophy of pyramidal tract
- Autoimmune cerebellar degeneration
- Autosomal dominant striatal neurodegeneration
- Autosomal recessive cerebral atrophy
- Beta-propeller protein-associated neurodegeneration
- Cerebellar ataxia associated with another disorder
- Cerebellar deficiency syndrome
- Cerebral degeneration in childhood
- Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder
- Chorea co-occurrent and due to dentatorubropallidoluysian degeneration
- Chorea co-occurrent and due to Huntington disease-like condition
- Chorea due to chronic hepatocerebral degeneration
- Chorea due to hereditary ataxia
- Chorea due to heredodegenerative disorder
- Chorea due to Huntington disease-like 1
- Chorea due to Huntington disease-like 2
- Chorea due to Huntington disease-like 3
- Choreoathetosis
- Chronic axonal neuropathy
- Chronic hepatocerebral degeneration
- CLCN6-related childhood-onset progressive neurodegeneration, peripheral neuropathy syndrome
- Coenzyme A synthase protein associated neurodegeneration
- Congenital cerebellar cortical atrophy
- Congenital microcephaly, severe encephalopathy, progressive cerebral atrophy syndrome
- Corneal cerebellar syndrome
- Cortical visual impairment
- Corticostriatal-spinal degeneration
- Cystic degeneration of brain
- Dentatorubropallidoluysian degeneration
- Diffuse atrophy of cerebellum
- Diffuse atrophy of cerebrum
- Diffuse cerebral and cerebellar atrophy, intractable seizures, progressive microcephaly syndrome
- Disorder of valine metabolism
- Early-onset neurodegeneration, choreoathetoid movement, microcytic anemia due to IREB2 mutation
- Early-onset progressive diffuse brain atrophy, microcephaly, muscle weakness, optic atrophy syndrome
- Early-onset progressive encephalopathy, hearing loss, pons hypoplasia, brain atrophy syndrome
- Early-onset progressive neurodegeneration, blindness, ataxia, spasticity syndrome
- Fatal post-viral neurodegenerative disorder
- Fatty acid hydroxylase associated neurodegeneration
- Generalized dystonia
- Global brain atrophy
- Global developmental delay, visual anomalies, progressive cerebellar atrophy, truncal hypotonia syndrome
- Hereditary acantholytic dermatosis
- Hereditary degenerative disease of central nervous system
- Huntington disease-like 1
- Huntington disease-like 3
- Huntington disease-like syndrome
- Huntington disease-like syndrome due to C9ORF72 expansions
- Hypomyelinating leukodystrophy with atrophy of basal ganglia and cerebellum
- Inborn error of amino acid metabolism
- Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly
- Infantile neuroaxonal dystrophy
- Infantile neurodegeneration, progressive spasticity, intellectual disability, white matter lesions syndrome
- Infantile spasms, psychomotor retardation, progressive brain atrophy, basal ganglia disease syndrome
- Infantile-onset axonal motor and sensory neuropathy, optic atrophy, neurodegenerative syndrome
- Juvenile cerebellar degeneration AND myoclonus
- Keratosis follicularis, dwarfism, cerebral atrophy syndrome
- Kufor Rakeb syndrome
- Late cortical cerebellar atrophy
- Late infantile and juvenile neuroaxonal dystrophy
- MEGDEL syndrome
- MEPAN syndrome
- Mitochondrial membrane protein associated neurodegeneration
- NADHX dehydratase deficiency
- NADHX epimerase deficiency
- NESCAV syndrome
- Neuroaxonal dystrophy
- Neurodegeneration due to 3-hydroxyisobutyryl coenzyme A hydrolase deficiency
- Neurodevelopmental delay, seizures, ophthalmic anomalies, osteopenia, cerebellar atrophy syndrome
- Olivopontocerebellar atrophy and deafness
- Olivopontocerebellar degeneration
- PCNA-related progressive neurodegenerative photosensitivity syndrome
- Peripheral axonal neuropathy
- Pineal degeneration
- PRKAR1B-related neurodegenerative dementia with intermediate filaments
- Progressive cerebello-cerebral atrophy
- Progressive chorea
- Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like syndrome
- Progressive neuronal degeneration of childhood
- Progressive neuronal degeneration without liver cirrhosis
- Progressive visual impairment
- Second cranial nerve finding
- Severe neurodegenerative syndrome with lipodystrophy
- Sporadic cerebellar degeneration
- Synucleinopathy
- TUBB4A-related leukodystrophy
- Type 1 diabetes mellitus, central and peripheral neurodegeneration syndrome
- USP18 deficiency
- X-linked neurodegenerative syndrome Bertini type
- X-linked neurodegenerative syndrome Hamel type
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to G31.89: its own notes plus those printed at G31 and Chapter 6. A note printed at a category, block or chapter applies to every code under it.
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
- Reye's syndrome (G93.7)
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Use Additional Code
Add a second code, after this one, to fully describe the condition.
- code, if applicable, for codes G31.0-G31.83, G31.85-G31.9, to identify:
- dementia with anxiety (F02.84, F02.A4, F02.B4, F02.C4)
- dementia with behavioral disturbance (F02.81-, F02.A1-, F02.B1-, F02.C1-)
- dementia with mood disturbance (F02.83, F02.A3, F02.B3, F02.C3)
- dementia with psychotic disturbance (F02.82, F02.A2, F02.B2, F02.C2)
- dementia without behavioral disturbance (F02.80, F02.A0, F02.B0, F02.C0)
- mild neurocognitive disorder due to known physiological condition (F06.7-)
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name G31.89, its category, or a range that includes it.
Use Additional Code 1
These codes say to use an additional code from the note, and G31.89 is one of the codes named.
- G31 Other degenerative diseases of nervous system, not elsewhere classified
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
brain (cortical) (progressive) G31.9
specified NEC G31.89
cystic G31.89
fatty G31.89
specified NEC G31.89
spinal (cord) G31.89
familial NEC G31.89
fatty G31.89
Syndrome See Also: Disease;
Seitelberger's G31.89
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Degenerative Nerve Diseases
Degenerative nerve diseases affect many of your body's activities, such as balance, movement, talking, breathing, and heart function. Many of these diseases are genetic. Sometimes the cause is a medical condition such as alcoholism, a tumor, or a stroke. Other causes may include toxins, chemicals, and viruses.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert G31.89 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About G31.89Overview
What is the ICD-10 code for other specified degenerative diseases of nervous system?
The ICD-10-CM code for other specified degenerative diseases of nervous system is G31.89 (sometimes written as G3189). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is G31.89 (Other specified degenerative diseases of nervous system) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report other specified degenerative diseases of nervous system on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does G31.89 group to?
When other specified degenerative diseases of nervous system is the principal diagnosis on an inpatient stay, it groups to MS-DRG 57, 56, with relative weights from 1.2835 to 2.2649 depending on complications. Higher weights mean higher Medicare reimbursement.
Does G31.89 need an additional code?
When the condition applies, yes. The Use Additional Code note at G31, which applies to G31.89, reads: code, if applicable, for codes G31.0-G31.83, G31.85-G31.9, to identify: dementia with anxiety (F02.84, F02.A4, F02.B4, F02.C4); dementia with behavioral disturbance (F02.81-, F02.A1-, F02.B1-, F02.C1-); dementia with mood disturbance (F02.83, F02.A3, F02.B3, F02.C3); dementia with psychotic disturbance (F02.82, F02.A2, F02.B2, F02.C2); dementia without behavioral disturbance (F02.80, F02.A0, F02.B0, F02.C0); and 1 more listed in the Instructional Notes section. The additional code is reported after G31.89.
What is the ICD-9 equivalent of G31.89?
Under the General Equivalence Mappings, other specified degenerative diseases of nervous system converts to ICD-9-CM 331.89 (cereb degeneration NEC). The mapping is approximate, so confirm the match fits the documentation.
Does G31.89 risk-adjust for Medicare Advantage payment?
Not for Medicare Advantage. G31.89 mapped to HCC 52 in the retired CMS-HCC V24 model, which last determined payment in 2025, but it maps to no category in the live V28 model; see all codes that no longer risk-adjust. It still risk-adjusts in the ESRD (V21) category 52 (Dementia Without Complication), ESRD (V24) category 52 (Dementia Without Complication), and RxHCC Part D (V08) category 112 (Dementia, Except Alzheimer's Disease).